OREM, Utah (PRWEB) February 14, 2018 — Accelerating the development of new digital cancer diagnostics in pathology is the aim of a new partnership between diagnostics pioneer Lumea and Southern Utah University (SUU).
Lumea is sponsoring the Digital Diagnostic Medical Research Initiative (DDx-MRI) at SUU. It will bring internationally recognized medical experts to the campus for research sabbaticals.
Dr. Matthew O. Leavitt, founder and chief medical officer of Lumea, said the collaboration “will open up research opportunities to expand Lumea’s ability to advance the way all cancer biopsies are processed, handled and evaluated.”
The first scholar-in-residence for DDx-MRI is Dr. Sorin Musat, Ph.D/MD, an anatomical pathologist from Romania and founder of a biotech firm in Canada. He holds several patents in pathology and introduced the first tissue microarray in routine clinical diagnostics. Musat is a graduate of Carol Davila University in Bucharest.
“SUU is an ideal environment for multi-partner research collaboration,” said Robert Eves, Dean of the SUU Walter Maxwell Gibson College of Science and Engineering. “The university is interested in providing quality experiences for faculty and students and welcomes research collaboration.”
Through the initiative, SUU students can apply for scholarships or college credit as they engage with the scholars-in-residence. It will provide research opportunities for students interested in histology, engineering, or medical research.
The Dixie and Anne Leavitt Family Foundation donated money to cover the housing and travel expenses for the scholars-in-residence. SUU is providing research space and a venue for visiting faculty summer seminars. Lumea will provide research funding for DDx-MRI projects.
Lumea is the market leader in the field of integrated digital pathology solutions. Its proprietary platform leverages new technologies to drive significant improvements in biopsy handling, tracking, workflow, and pathology sign-out. Lumea’s technology results in measurably better quality, increased efficiencies, and substantial cost savings throughout the diagnostic process.
